UK +44 (0)1223 491486      USA toll free 1-866 877 2185

Search
Generic filters
8 10, 2021

Qkine appoints Japanese distribution partner MBL to extend global availability of its innovative stem cell and organoid culture reagents

By |2021-10-08T12:15:37+00:00October 8th, 2021|animal-free, news, organoid news|Comments Off on Qkine appoints Japanese distribution partner MBL to extend global availability of its innovative stem cell and organoid culture reagents

Qkine has concluded a sales distribution agreement with Japanese company, MBL Medical & Biological Laboratories Co., Ltd. MBL have extensive knowledge and presence within the Japanese regenerative medicine and iPSC sector, an important market for Qkine's high purity, animal-free optimised growth factor and cytokine proteins. The two companies share a focus on product quality and the emerging areas of organoid and organ-on-chip technologies for basic research, personalised medicine and drug discovery. This distributor agreement between Qkine and MBL will facilitate access to Qkine's entire range of premium quality, animal-free and novel optimised growth factor proteins across Japan.

1 10, 2021

pep talk October 2021

By |2022-02-24T12:10:21+00:00October 1st, 2021|news, newsletter, resources, stem cells|Comments Off on pep talk October 2021

October update celebrating the launch of hyperstable FGF2-G3 for media optimisation, new media recipe quick reference resources for organoid researchers and the launch of animal-free OSM, which completes the hepatocyte differentiation growth factor set. Not forgetting us becoming an ISO9001: 2015 certified manufacturer!

10 09, 2021

Qkine earns ISO9001: 2015 certification for protein R&D and manufacture facilities in Cambridge, UK

By |2021-09-10T18:53:50+00:00September 10th, 2021|awards, cellular agriculture, news, press release, quality|Comments Off on Qkine earns ISO9001: 2015 certification for protein R&D and manufacture facilities in Cambridge, UK

Qkine certified ISO9001: 2015 for its quality management system encompassing R&D, manufacturing, and operations in Cambridge, UK. Qkine supplies growth factors and cytokines to the fast-moving stem cell, organoid and emerging cultured meat sectors. Exceptional product quality and scientific support are crucial to customer's business processes and experimental outcomes.

26 07, 2021

Qkine and Enantis sign licensing deal for hyperstable FGF2-STAB®

By |2021-07-26T08:14:57+00:00July 26th, 2021|animal-free, cellular agriculture, news, press release, protein engineering, protein science, stem cells|Comments Off on Qkine and Enantis sign licensing deal for hyperstable FGF2-STAB®

Qkine and Enantis have concluded a global licensing deal for Enantis’s patented FGF2-STAB® technology. FGF2-STAB® is a hyperstable form of FGF-2 (bFGF), a core reagent for stem cell culture. FGF2-STAB (FGF2-G3) does not degrade in culture media for enhanced weekend-free stem cell culture media and advanced chemically defined systems, such as those needed in the cultured meat industry.

10 06, 2021

pep talk June 2021

By |2022-02-24T12:11:07+00:00June 10th, 2021|news, newsletter, resources, stem cells|Comments Off on pep talk June 2021

June update with featured publication from Austin Smith lab, Kinoshita et al - capture of mouse and human stem cells with features of formative pluripotency; introduction to our "class of 2021" new products we've made this year; explaining pioneering proteins that bring innovative growth factors to stem cell researchers and free reconstitution solution to make lab life easy

10 03, 2021

pioneering proteins launch

By |2021-03-12T13:00:44+00:00March 10th, 2021|news, protein engineering, protein science|Comments Off on pioneering proteins launch

We are proud to launch our Pioneering Protein range! A range of modified proteins have been carefully developed by world leading academic laboratories, licenced through Cambridge Enterprise, and then manufactured to our high purity and bioactivity standards, bringing together academic innovation with high level manufacturing purity. Folloistatin-resistant activin A (FRACTA) has been developed by our [...]

8 03, 2021

Celebrating International Women’s Day 2021 with our amazing team, collaborators, customers and wider network

By |2022-02-07T13:34:31+00:00March 8th, 2021|news|Comments Off on Celebrating International Women’s Day 2021 with our amazing team, collaborators, customers and wider network

At Qkine we are so proud of all the wonderful women we work with! This #InternationalWomensDay we want to celebrate our amazing network and empower #WomenInSTEM to learn from and help each other #empoweringwomen #womenpower

8 03, 2021

Catherine Elton, Qkine founder and CEO, recognised in the #21towatch in 2021

By |2022-02-07T13:31:52+00:00March 8th, 2021|awards, news|Comments Off on Catherine Elton, Qkine founder and CEO, recognised in the #21towatch in 2021

The #21toWatch campaign showcases 7 people, 7 companies and 7 inventions at the forefront of innovation in Cambridge and the East of England. The results were announced on the 4th March and we are delighted that our CEO, Catherine Elton, was named one of the 7 “people” to watch.

25 11, 2020

Qkine, with UK biotechnology companies Manchester BIOGEL and Cellesce, is developing fully synthetic animal-free scaffolds to overcome barriers in sustainable and scalable organoid culture, in a project funded by Innovate UK

By |2022-02-07T13:30:35+00:00November 25th, 2020|animal-free, news, organoid news|Comments Off on Qkine, with UK biotechnology companies Manchester BIOGEL and Cellesce, is developing fully synthetic animal-free scaffolds to overcome barriers in sustainable and scalable organoid culture, in a project funded by Innovate UK

Qkine, Manchester BIOGEL and Cellesce have been awarded Innovate UK Sustainable Innovation Funding to develop fully synthetic, chemically-defined three-dimensional (3D) scaffolds to enable manufacture scale up and improve reproducibility of patient-derived organoids.

11 11, 2020

Qkine shortlisted in the Cambridge Independent 2020 Science & Technology awards

By |2022-02-07T13:29:16+00:00November 11th, 2020|awards, news|Comments Off on Qkine shortlisted in the Cambridge Independent 2020 Science & Technology awards

Qkine shortlisted in the Cambridge Independent 2020 Science & Technology awards Qkine is delighted to have been shortlisted in the prestigious Cambridge Independent 2020 Science and Technology Awards. Sponsored by Kao Data, the Startup of the Year shortlist recognises "early-stage companies that show entrepreneurial drive to solve a problem, or improve [...]

Title

Go to Top